SCHEMBL32668630

SCHEMBL32668630

Cc1cc(-n2ncc3c(=O)[nH]cnc32)ccc1Br

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.59
ALDH1A1 P00352 8/20 0.49
LMNA P02545 3/20 0.47
XBP1 P17861 1/20 0.47
MAPT P10636 5/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
TP53 P04637 1/20 0.43
KDM4E B2RXH2 5/20 0.42
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
GAA P10253 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
HPGD P15428 1/20 0.41
CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21525564 1.00 HTT (0.59) HTTALDH1A1LMNAXBP1MAPT
SCHEMBL21525512 0.85 HTT (0.59) HTTALDH1A1LMNAXBP1MAPT
SCHEMBL32668827 0.85 HTT (0.59) HTTALDH1A1LMNAXBP1MAPT
SCHEMBL17869860 0.81 HTT (0.67) HTTALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL4697615 0.81 HTT (0.53) HTTALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL3755962 0.80 HTT (0.65) HTTALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL3761515 0.79 HTT (0.64) HTTALDH1A1LMNAXBP1MAPT
SCHEMBL17869787 0.76 HTT (0.53) HTTALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL2077064 0.76 MAPT (0.59) HTTALDH1A1LMNAMAPTSMN1; SMN2
SCHEMBL17869621 0.75 XDH (0.60) HTTALDH1A1LMNAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3623372-B1 PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS VALO HEALTH INC (US) 2026-02-04 EP disclosed